BERLIN (Reuters) – Germany’s vaccination advisory commission STIKO recommended on Thursday that Pfizer-BioNTech’s, COVID-19 is given to children aged five to 11 with pre-existing conditions and said others could also request it.
The European Medicines Agency (EMA) on Nov. 25 cleared for use in younger children a dedicated 10 microgram vaccine version of the Pfizer/BioNTech shot that will be bottled by the manufacturers and delivered in Europe from Dec. 13.
Some German doctors have already begun vaccinating children under 12 with a lower dose of the adult vaccine but many have been waiting for the STIKO ruling, with vaccine campaigns for children already prepared across the country.
(Reporting by Emma Thomasson, editing by Kirsti Knolle)
